Empery Asset Management »

Clene shares owned by Empery Asset Management

Quarter-by-quarter ownership of Clene (CLNN) shares owned by Empery Asset Management from 13F filings

Historical chart of Empery Asset Management investment in Clene

Tip: Access up to 7 years of quarterly data

All positions including Clene held by Empery Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Clene by Empery Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.6M 917k 6.16

More positions owned by Empery Asset Management

X4 Pharmaceuticals Com New (XFOR)
Empery Digital Com New (EMPD)
Nervgen Pharma Ord (NGEN)
Precision Biosciences Com New (DTIL)
Clene Com New (CLNN)
Annovis Bio (ANVS)
Lantern Pharma (LTRN)
Amc Entmt Hldgs Cl A New (AMC)
Tenaya Therapeutics (TNYA)
One And One Green Technologi Usd Cl A Ord Shs (YDDL)
Cyngn Inc Com Par $0 00001 (CYN)
Venu Hldg Corp (VENU)
Greenland Energy *w Exp 04/21/203
Ur-energy (URG)
Satellos Bioscience (MSLE)

View all positions for Empery Asset Management

Top funds holding Clene

Empery Asset Management
Boxer Capital Management
SymBiosis Capital Partners
Vanguard Capital Management
Scoggin
Ensign Peak Advisors
Geode Capital Management
Lunt Capital Management
Peak6
Vanguard Fiduciary Trust
Parsons Capital Management
BlackRock
State Street Corporation
Morgan Stanley
Northern Trust

View all funds holding Clene